{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:41:15Z","timestamp":1792554075647,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cromwell Hospital"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01248-x","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:54:52Z","timestamp":1784969692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An interferonopathy associated with a monoallelic variant in TRIM28"],"prefix":"10.1186","volume":"24","author":[{"given":"Sonia Melo","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebun","family":"Omoyinmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bondet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A. Melo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"8","key":"1248_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","volume":"22","author":"YJ Crow","year":"2021","unstructured":"Crow YJ, Stetson DB. The type I interferonopathies: 10 years on. Nat Rev Immunol. 2021;22(8):471\u201383.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1248_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10067-011-1872-5","volume":"31","author":"D Eleftheriou","year":"2017","unstructured":"Eleftheriou D, Brogan PA. Genetic interferonopathies: An overview. Best practice & research. Clin Rheumatol. 2017;31(4):441\u201359.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"1248_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41390-019-0614-2","volume":"87","author":"HE S\u00f6nmez","year":"2020","unstructured":"S\u00f6nmez HE, Karaaslan C, de Jesus AA, Batu ED, Anlar B, S\u00f6zeri B, Bilginer Y, Karaguzel D, Cagdas Ayvaz D, Tezcan I, Goldbach-Mansky R, Ozen S. A clinical score to guide in decision making for monogenic type I IFNopathies. Pediatr Res. 2020;87(4):745\u201352.","journal-title":"Pediatr Res"},{"issue":"10","key":"1248_CR4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00109-016-1465-5","volume":"94","author":"H Kim","year":"2016","unstructured":"Kim H, Sanchez GA, Goldbach-Mansky R. Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus. J Mol Med. 2016;94(10):1111\u201327.","journal-title":"J Mol Med"},{"key":"1248_CR5","doi-asserted-by":"crossref","unstructured":"Maghsoudloo M, Mokhtari K, Jamali B, Gholamzad A, Entezari M, Hashemi M, Fu J. Multifaceted role of TRIM28 in health and disease. MedComm. 2024;5(11):e790.","DOI":"10.1002\/mco2.790"},{"key":"1248_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12867-015-0040-x","volume":"16","author":"H Bunch","year":"2015","unstructured":"Bunch H, Calderwood SK. TRIM28 as a novel transcriptional elongation factor. BMC Mol Biol. 2015;16:14.","journal-title":"BMC Mol Biol"},{"issue":"12","key":"1248_CR7","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1080\/15548627.2021.1909835","volume":"17","author":"J Chang","year":"2021","unstructured":"Chang J, Hwang HJ, Kim B, Choi YG, Park J, Park Y, Lee BS, Park H, Yoon MJ, Woo JS, Kim C, Park MS, Lee JB, Kim YK. TRIM28 functions as a negative regulator of aggresome formation. Autophagy. 2021;17(12):4231\u201348.","journal-title":"Autophagy"},{"key":"1248_CR8","doi-asserted-by":"crossref","unstructured":"Liang Q, Deng H, Li X, Wu X, Tang Q, Chang TH, Peng H, Rauscher FJ 3rd, Ozato K, Zhu F. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. J Immunol. 2011;187(9):4754\u201363.","DOI":"10.4049\/jimmunol.1101704"},{"key":"1248_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fimmu.2019.00325","volume":"10","author":"CA Jefferies","year":"2019","unstructured":"Jefferies CA. Regulating IRFs in IFN Driven Disease. Front Immunol. 2019;10:325.","journal-title":"Front Immunol"},{"issue":"7034","key":"1248_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nature03464","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434(7034):772\u20137.","journal-title":"Nature"},{"issue":"6","key":"1248_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gene.2011.21","volume":"12","author":"S Ning","year":"2011","unstructured":"Ning S, Pagano JS, Barber GN. IRF7: activation, regulation, modification and function. Genes Immun. 2011;12(6):399\u2013414.","journal-title":"Genes Immun"},{"issue":"37","key":"1248_CR12","doi-asserted-by":"publisher","first-page":"25660","DOI":"10.1074\/jbc.M804479200","volume":"283","author":"T Kubota","year":"2008","unstructured":"Kubota T, Matsuoka M, Chang TH, Tailor P, Sasaki T, Tashiro M, Kato A, Ozato K. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J Biol Chem. 2008;283(37):25660\u201370.","journal-title":"J Biol Chem"},{"issue":"11","key":"1248_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2019-215208","volume":"78","author":"M Wu","year":"2019","unstructured":"Wu M, Skaug B, Bi X, Mills T, Salazar G, Zhou X, Reveille J, Agarwal SK, Blackburn MR, Mayes MD, Assassi S. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis. Ann Rheum Dis. 2019;78(11):1583\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"1248_CR14","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The sequence alignment\/map format and SAM tools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"7","key":"1248_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/jmedgenet-2012-100918","volume":"49","author":"X Chang","year":"2012","unstructured":"Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012;49(7):433\u20136.","journal-title":"J Med Genet"},{"key":"1248_CR16","doi-asserted-by":"crossref","unstructured":"Omoyinmi E, Standing A, Keylock A, Price-Kuehne F, Gomes M, Rowczenio S, Nanthapisal D, Cullup S, Nyanhete T, Ashton R, Murphy E, Clarke C, Ahlfors M, Jenkins H, Gilmour L, Eleftheriou K, Lachmann D, Hawkins PN, Klein N, Brogan PA. Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis. PLoS One. 2017;12(7):e0181874.","DOI":"10.1371\/journal.pone.0181874"},{"key":"1248_CR17","doi-asserted-by":"crossref","unstructured":"Burleigh, A., Moraitis, E., Al Masroori, E., Al-Abadi, E., Hong, Y., Omoyinmi, E.,Titheradge, H., Stals, K., Jones, W. D., Gait, A., Jayarajan, V., Di, W. L., Sebire,N., Solman, L., Ogboli, M., Welch, S. B., Sudarsanam, A., Wacogne, I., Price-Kuehne,F., Jensen, B., \u2026 Eleftheriou, D. Case report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition. Front Immunol. 2023;14:1287258.","DOI":"10.3389\/fimmu.2023.1287258"},{"key":"1248_CR18","doi-asserted-by":"crossref","unstructured":"Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, Ackroyd S, Allcock R, Bailey KM, Balottin U, Barnerias C, Bernard G, Bodemer C, Botella MP, Cereda C, Chandler KE, Dabydeen L, Dale RC, De Laet C, De Goede CG, Toro D, Effat M, Enamorado L, Fazzi NN, Gener E, Haldre B, Lin MS-M, Livingston JP, Lourenco JH, Marques CM, Jr W, Oades P, Peterson P, Rasmussen M, Roubertie A, Schmidt JL, Shalev SA, Simon R, Spiegel R, Swoboda KJ, Temtamy SA, Vassallo G, Vilain CN, Vogt J, Wermendol V, Whitehpose WP, Soler D, Olivieri I, Orcesi S, Aglan MS, Zaki MS, Abdel-Salam GMH, Vanderver A, Kisand K, Rozenberg F, Lebon P, Crow YJ. Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 2013;12(12):1159\u201369.","DOI":"10.1016\/S1474-4422(13)70258-8"},{"issue":"5","key":"1248_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.20161451","volume":"214","author":"MP Rodero","year":"2017","unstructured":"Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, McGlasson SL, Alyanakian MA, Bader-Meunier B, Barnerias C, Bellon N, Belot A, Bodemer C, Briggs TA, Desguerre I, Fr\u00e9mond ML, Hully M, van den Maagdenberg A, Melki I, Meyts I, Musset L, Pelzer N, Quartier P, Terwindt GM, Wardlaw J, Wiseman S, Rieux-Laucat F, Rose Y, Neven B, Hertel C, Hayday A, Albert ML, Rozenberg F, Crow YJ, Duffy D. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J Exp Med. 2017;214(5):1547\u201355.","journal-title":"J Exp Med"},{"issue":"2","key":"1248_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00005792-199303000-00004","volume":"72","author":"PJ Maddison","year":"1993","unstructured":"Maddison PJ, Stephens C, Briggs D, Welsh KI, Harvey G, Whyte J, McHugh N, Black CM. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group. Medicine. 1993;72(2):103\u201312.","journal-title":"Medicine"},{"issue":"24","key":"1248_CR21","doi-asserted-by":"publisher","first-page":"dev193649","DOI":"10.1242\/dev.193649","volume":"147","author":"A Patel","year":"2020","unstructured":"Patel A, Anderson G, Galea GL, Balys M, Sowden JC. A molecular and cellular analysis of human embryonic optic fissure closure related to the eye malformation coloboma. Development. 2020;147(24):dev193649.","journal-title":"Development"},{"key":"1248_CR22","doi-asserted-by":"publisher","first-page":"852830","DOI":"10.3389\/fimmu.2022.852830","volume":"13","author":"Y Hong","year":"2022","unstructured":"Hong Y, Casimir M, Houghton BC, Zhang F, Jensen B, Omoyinmi E, Torrance R, Papadopoulou C, Cummins M, Roderick M, Thrasher AJ, Brogan PA, Eleftheriou D. Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2. Front Immunol. 2022;13:852830.","journal-title":"Front Immunol"},{"key":"1248_CR23","unstructured":"Broad Institute. GnomAD, the genome aggregation database: http:\/\/www.gnomad.broadinstitute.orgaccessed8\/11\/2025."},{"issue":"2","key":"1248_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/cpt.936","volume":"104","author":"H Kim","year":"2018","unstructured":"Kim H, Brooks KM, Tang CC, Wakim P, Blake M, Brooks SR, Montealegre Sanchez GA, de Jesus AA, Huang Y, Tsai WL, Gadina M, Prakash A, Janes JM, Zhang X, Macias WL, Kumar P, Goldbach-Mansky R. Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients. Clin Pharmacol Ther. 2018;104(2):364\u201373.","journal-title":"Clin Pharmacol Ther"},{"key":"1248_CR25","doi-asserted-by":"crossref","unstructured":"Sanchez G, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O\u2019Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL. & Goldbach-Mansky, R. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128(7):3041\u201352.","DOI":"10.1172\/JCI98814"},{"issue":"6","key":"1248_CR26","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","volume":"138","author":"ML Fr\u00e9mond","year":"2016","unstructured":"Fr\u00e9mond ML, Rodero MP, Jeremiah N, Belot A, Jeziorski E, Duffy D, Bessis D, Cros G, Rice GI, Charbit B, Hulin A, Khoudour N, Caballero CM, Bodemer C, Fabre M, Berteloot L, Le Bourgeois M, Reix P, Walzer T, Moshous D, Blanche S, Fischer A, Bader-Meunier B, Rieux-Laucat F, Crow YJ, Neven B. Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children. J Allergy Clin Immunol. 2016;138(6):1752\u20135.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1248_CR27","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1038\/s41598-022-10777-w","volume":"12","author":"L Hoisnard","year":"2022","unstructured":"Hoisnard L, Lebrun-Vignes B, Maury S, Mahevas M, El Karoui K, Roy L, Zarour A, Michel M, Cohen JL, Amiot A, Claudepierre P, Wolkenstein P, Grimbert P, Sbidian E. Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database. Sci Rep. 2022;12(1):7140.","journal-title":"Sci Rep"},{"issue":"3","key":"1248_CR28","first-page":"101975","volume":"38","author":"LO Mendon\u00e7a","year":"2024","unstructured":"Mendon\u00e7a LO, Fr\u00e9mond ML. Interferonopathies: From concept to clinical practice. Best practice & research. Clin Rheumatol. 2024;38(3):101975.","journal-title":"Clin Rheumatol"},{"key":"1248_CR29","doi-asserted-by":"crossref","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O\u2019Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME; Genome Aggregation Database Consortium, Neale, B.M., Daly MJ, MacArthur. D. G. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","DOI":"10.1038\/s41586-020-2308-7"},{"issue":"5","key":"1248_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet medicine: official J Am Coll Med Genet. 2015;17(5):405\u201324.","journal-title":"Genet medicine: official J Am Coll Med Genet"},{"issue":"10","key":"1248_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M, Topper S, Invitae Clinical Genomics Group. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet medicine: official J Am Coll Med Genet. 2017;19(10):1105\u201317.","journal-title":"Genet medicine: official J Am Coll Med Genet"},{"key":"1248_CR32","doi-asserted-by":"crossref","unstructured":"Rice GI, Park S, Gavazzi F, Adang LA, Ayuk LA, Van Eyck L, Seabra L, Barrea C, Battini R, Belot A, Berg S, Billette de Villemeur T, Bley AE, Blumkin L, Boespflug-Tanguy O, Briggs TA, Brimble E, Dale RC, Darin N, Debray FG, De Giorgis V, Denecke J, Doummar D, Hagelsrum GDA, Eleftheriou D, Estienne M, Fazzi E, Feillet F, Galli J, Hartog N, Harvengt J, Heron B, heron D, Kelly DA, Lev D, Levrat V, Livingstone JH, Marti I, Mignot C, Mochel F, Nougues M-C, Oppermann I, Perez-Duenas B, Popp B, Rodero MP, Rodriguez D, Saletti V, Sharpe C, Tonduti D, Vadlamani G, Van Haren K, Vila MT, Vogt J, Wassmer E, Wiedemann A, Wilson CJ, Zerem A, Zweier C, Zuberi SM, Orcesi S, Vanderver AL, Hur S, Crow YJ. Genetic and phenotypic spectrum associated with IFIH1 gain-of-function. Hum Mutat. 2020;41(4):837\u201349.","DOI":"10.1002\/humu.23975"},{"issue":"6\u20137","key":"1248_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00439-020-02131-9","volume":"139","author":"C Gruber","year":"2020","unstructured":"Gruber C, Bogunovic D. Incomplete penetrance in primary immunodeficiency: a skeleton in the closet. Hum Genet. 2020;139(6\u20137):745\u201357.","journal-title":"Hum Genet"},{"key":"1248_CR34","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3389\/fimmu.2019.02770","volume":"10","author":"S Keskitalo","year":"2019","unstructured":"Keskitalo S, Haapaniemi E, Einarsdottir E, Rajam\u00e4ki K, Heikkil\u00e4 H, Ilander M, P\u00f6yh\u00f6nen M, Morgunova E, Hokynar K, Lagstr\u00f6m S, Kivirikko S, Mustjoki S, Eklund K, Saarela J, Kere J, Sepp\u00e4nen M, Ranki A, Hannula-Jouppi K, Varjosalo M. Novel TMEM173 Mutation and the Role of Disease Modifying Alleles. Front Immunol. 2019;10:2770.","journal-title":"Front Immunol"},{"issue":"20","key":"1248_CR35","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1093\/hmg\/ddh275","volume":"13","author":"HD Shin","year":"2004","unstructured":"Shin HD, Park BL, Kim LH, Lee HS, Kim TY, Bae SC. Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum Mol Genet. 2004;13(20):2343\u201350.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"1248_CR36","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/art.38117","volume":"65","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Wu J, Kucik DF, White NB, Redden DT, Szalai AJ, Bullard DC, Edberg JC. Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils. Arthritis Rheum. 2013;65(11):2907\u201316.","journal-title":"Arthritis Rheum"},{"key":"1248_CR37","doi-asserted-by":"crossref","unstructured":"Faridi, M. H., Khan, S. Q., Zhao, W., Lee, H. W., Altintas, M. M., Zhang, K., Kumar,V., Armstrong, A. R., Carmona-Rivera, C., Dorschner, J. M., Schnaith, A. M., Li, X.,Ghodke-Puranik, Y., Moore, E., Purmalek, M., Irizarry-Caro, J., Zhang, T., Day, R.,Stoub, D., Hoffmann, V., \u2026 Gupta, V. (2017). CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017;127(4):1271\u201383.","DOI":"10.1172\/JCI88442"},{"issue":"1","key":"1248_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41435-018-0029-9","volume":"20","author":"S Patel","year":"2019","unstructured":"Patel S, Jin L. TMEM173 variants and potential importance to human biology and disease. Genes Immun. 2019;20(1):82\u20139.","journal-title":"Genes Immun"},{"issue":"1","key":"1248_CR39","doi-asserted-by":"publisher","first-page":"19541","DOI":"10.1038\/s41598-023-46830-5","volume":"13","author":"G Froechlich","year":"2023","unstructured":"Froechlich G, Finizio A, Napolano A, Amiranda S, De Chiara A, Pagano P, Mallardo M, Leoni G, Zambrano N, Sasso E. The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties. Sci Rep. 2023;13(1):19541.","journal-title":"Sci Rep"},{"issue":"4","key":"1248_CR40","doi-asserted-by":"publisher","first-page":"e20242179","DOI":"10.1084\/jem.20242179","volume":"222","author":"N Simchoni","year":"2025","unstructured":"Simchoni N, Koidey S, Likhite M, Kuchitsu Y, Kadirvel S, Law CS, Elicker BM, Kurra S, Wong MM, Yuan B, Grossi A, Laxer RM, Volpi S, Dissanayake D, Taguchi T, Beck DB, Vogel TP, Shum AK. The common HAQ STING allele prevents clinical penetrance of COPA syndrome. J Exp Med. 2025;222(4):e20242179.","journal-title":"J Exp Med"},{"issue":"4","key":"1248_CR41","first-page":"e82254","volume":"17","author":"S Lehrer","year":"2025","unstructured":"Lehrer S. Interaction Between HAQ-STING Mutation and COPA: Protection Against COPA Syndrome. Cureus. 2025;17(4):e82254.","journal-title":"Cureus"},{"key":"1248_CR42","doi-asserted-by":"publisher","first-page":"920390","DOI":"10.3389\/fgene.2022.920390","volume":"13","author":"R Kingdom","year":"2022","unstructured":"Kingdom R, Wright CF. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts. Front Genet. 2022;13:920390.","journal-title":"Front Genet"},{"issue":"8048","key":"1248_CR43","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41586-024-08346-4","volume":"637","author":"O Stewart","year":"2025","unstructured":"Stewart O, Gruber C, Randolph HE, Patel R, Ramba M, Calzoni E, Huang LH, Levy J, Buta S, Lee A, Sazeides C, Prue Z, van Hoytema DP, Chinn IK, Pedroza LA, Lupski JR, Schmitt EG, Cooper MA, Puel A, Peng X, Boisson-Dupuis S, Bustamante J, Okada S, Martin-Fernandez M, Orange JS, Casanova JL, Bogunovic D. Monoallelic expression can govern penetrance of inborn errors of immunity. Nature. 2025;637(8048):1186\u201397. https:\/\/doi.org\/10.1038\/s41586-024-08346-4.","journal-title":"Nature"},{"key":"1248_CR44","doi-asserted-by":"publisher","first-page":"834636","DOI":"10.3389\/fcimb.2022.834636","volume":"12","author":"K Randolph","year":"2022","unstructured":"Randolph K, Hyder U, D\u2019Orso I. KAP1\/TRIM28: Transcriptional Activator and\/or Repressor of Viral and Cellular Programs? Front Cell Infect Microbiol. 2022;12:834636.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"1248_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, Ishiguro N, Ueda-Hayakawa I, Asano Y, Ogawa F, Fujikawa K, Miyagi T, Mabuchi E, Hirose K, Akimoto N, Hatta N, Tsutsui K, Higashi A, Igarashi A, Seishima M, Hasegawa M, Takehara K. Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 2012;64(2):513\u201322.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1248_CR46","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/ar3802","volume":"14","author":"M Satoh","year":"2012","unstructured":"Satoh M, Chan JY, Ross SJ, Li Y, Yamasaki Y, Yamada H, Vazquez-del Mercado M, Petri MH, Jara LJ, Saavedra MA, Cruz-Reyes C, Sobel ES, Reeves WH, Ceribelli A, Chan EK. Autoantibodies to transcription intermediary factor TIF1\u03b2 associated with dermatomyositis. Arthritis Res therapy. 2012;14(2):R79.","journal-title":"Arthritis Res therapy"},{"issue":"4","key":"1248_CR47","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/bjd.17098","volume":"180","author":"I Ueda-Hayakawa","year":"2019","unstructured":"Ueda-Hayakawa I, Hamaguchi Y, Okiyama N, Motegi S, Yamaoka T, Miyake S, Higashi A, Okamoto H, Takehara K, Fujimoto M. Autoantibody to transcriptional intermediary factor-1\u03b2 as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy. Br J Dermatol. 2019;180(4):881\u20137.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1248_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13075-020-02160-9","volume":"22","author":"H Kim","year":"2020","unstructured":"Kim H, Gunter-Rahman F, McGrath JA, Lee E, de Jesus AA, Targoff IN, Huang Y, O\u2019Hanlon TP, Tsai WL, Gadina M, Miller FW, Goldbach-Mansky R, Rider LG. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res therapy. 2020;22(1):69.","journal-title":"Arthritis Res therapy"},{"issue":"6","key":"1248_CR49","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/1744666X.2024.2312819","volume":"20","author":"H Kim","year":"2024","unstructured":"Kim H. Updates on efficacy and safety janus kinase inhibitors in juvenile dermatomyositis. Expert Rev Clin Immunol. 2024;20(6):589\u2013602.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"1248_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/BOR.0000000000000816","volume":"33","author":"H Kim","year":"2021","unstructured":"Kim H. Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy. Curr Opin Rheumatol. 2021;33(5):371\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1248_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12969-021-00637-8","volume":"19","author":"MG Ll Wilkinson","year":"2021","unstructured":"Ll Wilkinson MG, Deakin CT, Papadopoulou C, Eleftheriou D, Wedderburn LR. JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology. Pediatr Rheumatol Online J. 2021;19(1):146.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"1248_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41584-023-00967-9","volume":"19","author":"C Papadopoulou","year":"2023","unstructured":"Papadopoulou C, Chew C, Wilkinson MGL, McCann L, Wedderburn LR. Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care. Nat Rev Rheumatol. 2023;19(6):343\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"1248_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","volume":"84","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Simou S, Shaddick G, Betteridge ZE, Almeida B, Gunawardena H, Thomson W, Beresford MW, Midgley A, Muntoni F, Wedderburn LR, McHugh NJ. Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun. 2017;84:55\u201364.","journal-title":"J Autoimmun"},{"issue":"1","key":"1248_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40272-024-00658-2","volume":"27","author":"H Kim","year":"2025","unstructured":"Kim H. Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies. Paediatr Drugs. 2025;27(1):57\u201372.","journal-title":"Paediatr Drugs"},{"key":"1248_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.coi.2015.01.005","volume":"32","author":"B Boisson","year":"2015","unstructured":"Boisson B, Quartier P, Casanova JL. Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind. Curr Opin Immunol. 2015;32:90\u2013105.","journal-title":"Curr Opin Immunol"},{"key":"1248_CR56","doi-asserted-by":"crossref","unstructured":"Veitia RA, Zschocke J, Birchler JA. Gene dosage sensitivity and human genetic diseases. J Inherit Metab Dis. 2025;48(4):e70058.","DOI":"10.1002\/jimd.70058"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01248-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01248-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:09:08Z","timestamp":1792552148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01248-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01248-x","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study had the full approval of the medical ethics committee of Great Ormond Street Hospital NHS Foundation Trust (GOSH) (REC reference 08\/H0713\/82). All participants consented to participate in this study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written consent was obtained from the family after the proband\u2019s death.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"78"}}